101 related articles for article (PubMed ID: 11441114)
1. Tissue-type plasminogen activator deficiency exacerbates arthritis.
Yang YH; Carmeliet P; Hamilton JA
J Immunol; 2001 Jul; 167(2):1047-52. PubMed ID: 11441114
[TBL] [Abstract][Full Text] [Related]
2. Differing roles for urokinase and tissue-type plasminogen activator in collagen-induced arthritis.
Cook AD; Braine EL; Campbell IK; Hamilton JA
Am J Pathol; 2002 Mar; 160(3):917-26. PubMed ID: 11891190
[TBL] [Abstract][Full Text] [Related]
3. The effect of tissue type-plasminogen activator deletion and associated fibrin(ogen) deposition on macrophage localization in peritoneal inflammation.
Cook AD; Vlahos R; Massa CM; Braine EL; Lenzo JC; Turner AL; Way KJ; Hamilton JA
Thromb Haemost; 2006 Apr; 95(4):659-67. PubMed ID: 16601837
[TBL] [Abstract][Full Text] [Related]
4. Urokinase-type plasminogen activator and arthritis progression: role in systemic disease with immune complex involvement.
Cook AD; De Nardo CM; Braine EL; Turner AL; Vlahos R; Way KJ; Beckman SK; Lenzo JC; Hamilton JA
Arthritis Res Ther; 2010; 12(2):R37. PubMed ID: 20196869
[TBL] [Abstract][Full Text] [Related]
5. Physiological consequences of loss of plasminogen activator gene function in mice.
Carmeliet P; Schoonjans L; Kieckens L; Ream B; Degen J; Bronson R; De Vos R; van den Oord JJ; Collen D; Mulligan RC
Nature; 1994 Mar; 368(6470):419-24. PubMed ID: 8133887
[TBL] [Abstract][Full Text] [Related]
6. Urokinase-type plasminogen activator and arthritis progression: contrasting roles in systemic and monoarticular arthritis models.
De Nardo CM; Lenzo JC; Pobjoy J; Hamilton JA; Cook AD
Arthritis Res Ther; 2010; 12(5):R199. PubMed ID: 20973954
[TBL] [Abstract][Full Text] [Related]
7. Genetic deletion of tissue-type plasminogen activator (t-PA) in APOE3-Leiden mice reduces progression of cholesterol-induced atherosclerosis.
Rezaee F; Gijbels M; Offerman E; Verheijen J
Thromb Haemost; 2003 Oct; 90(4):710-6. PubMed ID: 14515193
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes.
Lijnen HR; Wagner EF; Collen D
Thromb Haemost; 1997 Feb; 77(2):362-7. PubMed ID: 9157597
[TBL] [Abstract][Full Text] [Related]
9. Influence of t-pA and u-PA on adipose tissue development in a murine model of diet-induced obesity.
Morange PE; Bastelica D; Bonzi MF; Van Hoef B; Collen D; Juhan-Vague I; Lijnen HR
Thromb Haemost; 2002 Feb; 87(2):306-10. PubMed ID: 11858492
[TBL] [Abstract][Full Text] [Related]
10. Exacerbation of antigen-induced arthritis in urokinase-deficient mice.
Busso N; Péclat V; Van Ness K; Kolodziesczyk E; Degen J; Bugge T; So A
J Clin Invest; 1998 Jul; 102(1):41-50. PubMed ID: 9649555
[TBL] [Abstract][Full Text] [Related]
11. Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor.
Lawlor KE; Wong PK; Campbell IK; van Rooijen N; Wicks IP
Arthritis Rheum; 2005 Dec; 52(12):3749-54. PubMed ID: 16320325
[TBL] [Abstract][Full Text] [Related]
12. Mice deficient in urokinase-type plasminogen activator have delayed healing of tympanic membrane perforations.
Shen Y; Guo Y; Du C; Wilczynska M; Hellström S; Ny T
PLoS One; 2012; 7(12):e51303. PubMed ID: 23236466
[TBL] [Abstract][Full Text] [Related]
13. Biological effects of disruption of the tissue-type plasminogen activator, urokinase-type plasminogen activator, and plasminogen activator inhibitor-1 genes in mice.
Carmeliet P; Bouché A; De Clercq C; Janssen S; Pollefeyt S; Wyns S; Mulligan RC; Collen D
Ann N Y Acad Sci; 1995 Jan; 748():367-81; discussion 381-2. PubMed ID: 7695179
[No Abstract] [Full Text] [Related]
14. The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system.
Swaisgood CM; French EL; Noga C; Simon RH; Ploplis VA
Am J Pathol; 2000 Jul; 157(1):177-87. PubMed ID: 10880388
[TBL] [Abstract][Full Text] [Related]
15. Ovulation efficiency is reduced in mice that lack plasminogen activator gene function: functional redundancy among physiological plasminogen activators.
Leonardsson G; Peng XR; Liu K; Nordström L; Carmeliet P; Mulligan R; Collen D; Ny T
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12446-50. PubMed ID: 8618918
[TBL] [Abstract][Full Text] [Related]
16. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N
Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727
[TBL] [Abstract][Full Text] [Related]
17. Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA).
Nelles L; Lijnen HR; Van Nuffelen A; Demarsin E; Collen D
Thromb Haemost; 1990 Aug; 64(1):53-60. PubMed ID: 2148847
[TBL] [Abstract][Full Text] [Related]
18. Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation.
Brommer EJ; Dooijewaard G; Dijkmans BA; Breedveld FC
Thromb Haemost; 1992 Aug; 68(2):180-4. PubMed ID: 1412164
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.
Lund LR; Green KA; Stoop AA; Ploug M; Almholt K; Lilla J; Nielsen BS; Christensen IJ; Craik CS; Werb Z; Danø K; Rømer J
EMBO J; 2006 Jun; 25(12):2686-97. PubMed ID: 16763560
[TBL] [Abstract][Full Text] [Related]
20. The role of the fibrinolytic system in corneal angiogenesis.
Vogten JM; Reijerkerk A; Meijers JC; Voest EE; Borel Rinkes IH; Gebbink MF
Angiogenesis; 2003; 6(4):311-6. PubMed ID: 15166500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
